Allogene Therapeutics, Inc. (ALLO) insider trading
Over the last 12 months, 0 insiders bought $0 and 6 insiders sold $620K of Allogene Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Aug 21, 2026: Douglas Earl Martin sold 29,697 shares ($63.0K)
- Apr 21, 2026: Yoshiyama Annie sold 9,586 shares ($22.1K)
- Mar 31, 2026: Beneski Benjamin Machinas sold 2,867 shares ($7.17K)
- Mar 16, 2026: Chang David D sold 47,763 shares ($118K)
- Mar 16, 2026: Beneski Benjamin Machinas sold 4,835 shares ($11.9K)
- Mar 2, 2026: Beneski Benjamin Machinas sold 7,132 shares ($18.5K)
- Feb 2, 2026: Douglas Earl Martin sold 22,900 shares ($40.3K)
- Feb 2, 2026: Roberts Zachary sold 35,700 shares ($63.2K)
- Feb 2, 2026: Yoshiyama Annie sold 4,167 shares ($7.17K)
- Feb 2, 2026: Parker Geoffrey M. sold 24,001 shares ($42.2K)